European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.

AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of MAVIRET® ...

AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of its treatment for acute hepatitis C. The final ...

National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that ...

In the wake of recent breakthroughs in the management of hepatitis C virus (HCV) infection, with several new promising medications available on the market and more being studied in clinical trials, it ...

EMA committee recommends approval for AbbVie’s Maviret for the treatment of acute hepatitis C infection: North Chicago, Illinois Monday, May 25, 2026, 18:00 Hrs [IST] AbbVie, an ...

Please provide your email address to receive an email when new articles are posted on . Chronic HCV infection was associated with a 1.8-fold increased risk for pancreatic ductal adenocarcinoma.

Hepatitis C is a viral infection that affects your liver. You may not have symptoms. Hepatitis C is a viral infection caused by the hepatitis C virus (HCV) that affects the liver. It can be acute or ...

In a recent article published in eClinicalMedicine, researchers estimate the seroprevalence of hepatitis C virus (HCV) in pregnant women globally and in World Health Organization (WHO)-specific ...

In this study, an attempt has been made to evaluate potentially significant clinical-pathologic differences in HCC's that develop in association with chronic HBV vs. HCV. Comparisons have been made ...

Hepatitis C is a viral infection that causes inflammation of the liver. Over time, the hepatitis C virus (HCV) can cause permanent liver damage. People usually contract HCV after coming into contact ...